An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancer
To access this article, please choose from the options below
PII: S0959-8049(07)00863-5
doi:10.1016/j.ejca.2007.11.003
© 2007 Elsevier Ltd. All rights reserved.
